Federal Reserve Maintains Interest Rates Amid Political Transition and Economic Headwinds
, , ,

Federal Reserve Maintains Interest Rates Amid Political Transition and Economic Headwinds

The Federal Reserve has officially decided to hold interest rates steady within the 3.5% to 3.75% range. This decision reflects a cautious stance as the central bank balances persistent inflationary pressures—which reached 3.3% in March—against a backdrop of global geopolitical instability, specifically the ongoing conflict between the United States and Iran. Rising energy costs have […]

Bitcoin Dips Below $75K as Fed Stays Hawkish, Crypto Stocks Face Sell-Off
, ,

Bitcoin Dips Below $75K as Fed Stays Hawkish, Crypto Stocks Face Sell-Off

Bitcoin experienced a notable price dip, briefly falling below the $75,000 mark on Wednesday. This decline occurred as the U.S. Federal Reserve announced its decision to maintain current interest rates, dampening immediate expectations for rate cuts and contributing to a broader sell-off across risk-sensitive assets. The Federal Reserve’s stance signaled a more cautious approach to […]

As Gas Prices Force Americans to Drive Less, Pay-Per-Mile Insurance Emerges as a Major Money Saver
, , ,

As Gas Prices Force Americans to Drive Less, Pay-Per-Mile Insurance Emerges as a Major Money Saver

Rising fuel costs have forced a significant shift in American driving habits. With average regular gasoline prices climbing past $4.18 per gallon—marking a multi-year high—more than half of U.S. motorists are actively choosing to scale back their time on the road. However, simply reducing mileage does not automatically translate to lower premiums on standard auto […]

Pharma Titans AstraZeneca and GSK Outperform Q1 Expectations Amid Regulatory Uncertainty
, , ,

Pharma Titans AstraZeneca and GSK Outperform Q1 Expectations Amid Regulatory Uncertainty

AstraZeneca and GSK have started 2026 on a strong financial footing, delivering first-quarter results that comfortably surpassed market expectations. AstraZeneca reported a core earnings per share (EPS) of $2.58, beating the anticipated $2.53, while GSK posted a core EPS of £0.47, exceeding the projected £0.43. Both pharmaceutical giants have reaffirmed their full-year financial guidance, reflecting […]